UltraSight, formerly OnSight Medical, is a Tel Aviv-based digital health company that develops an AI platform for ultrasound devices to perform real-time sonography at the point of care. Its core product provides real-time AI guidance for cardiac imaging across clinics, community hospitals, ambulances and remote settings. The company recently raised $13M in a Series B funding round. UltraSight intends to use the funds to advance U.S. clinical programs for its real-time AI guidance in a variety of care settings. Led by CEO Davidi Vortman, UltraSight aims to enable medical professionals to diagnose patients wherever they are. The company focuses on point-of-care sonography to expand access to cardiac imaging.

Total raised

$13M

Funding rounds

1

Latest round

Series B

Latest activity

May 2021